This is a review about ERK1, based on 211 published articles (read how Labome selects the articles), using ERK1 antibody in all methods. It is aimed to help Labome visitors find the most suited ERK1 antibody.
ERK1 synonym: ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK; MAP kinase 1; MAP kinase 3; MAP kinase isoform p44; MAPK 1; extracellular signal-regulated kinase 1; extracellular signal-related kinase 1; insulin-stimulated MAP2 kinase; microtubule-associated protein 2 kinase; mitogen-activated protein kinase 1

Santa Cruz BiotechnologySanta Cruz Biotechnology ERK1 product
  • immunocytochemistryIn 2004, Lijun Xu et al. used Santa Cruz Biotechnology ERK1 antibody to study the role of NNK for lung cancer cell migration and invasion in a mechanism involving phosphorylation of calpains [ncbi , more ].
  • immunohistochemistryIn 2006, Vijay Koka et al. applied Santa Cruz Biotechnology ERK1 antibody to study the effect of advanced glycation end products on chymase-dependent angiotensin II generating pathway in diabetic complications [ncbi , more ]. In 2002, Shazli N Malik et al. used Santa Cruz Biotechnology ERK1 antibody to study the expression of phospho-specific Akt in human prostate cancer [ncbi , more ].
  • immunoprecipitationIn 2009, Berta Casar et al. applied Santa Cruz Biotechnology ERK1 antibody to show extracellular signal-regulated kinase 1 and 2 substrate specificity [ncbi , more ]. In 2006, Yanzhong Hu et al. employed Santa Cruz Biotechnology ERK1 antibody to study the role for the interaction of DUSP26 with Hsf4b in the MAP kinase signaling pathway in human lung carcinoma cell line H1299 [ncbi , more ]. Jong Wook Hong et al. utilized Santa Cruz Biotechnology ERK1 antibody to study the interaction of tis21 protein with Pin-1 after phosphorylation of its Ser147 residue by p-Erk1/2 [ncbi , more ] in 2005 and Tie Li et al. used Santa Cruz Biotechnology ERK1 antibody to study epidermal growth factor-induced corneal epithelial cell proliferation [ncbi , more ]. In 2004, Mizuo Mifune et al. utilized Santa Cruz Biotechnology ERK1 antibody to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ]. In 2003, Hema Vaidyanathan et al. used Santa Cruz Biotechnology ERK1 antibody to demonstrate RSK2 activity is regulated by its interaction with PEA-15 [ncbi , more ]. In 2000, D L Persons et al. employed Santa Cruz Biotechnology ERK1 antibody to precipitate ERK1/2 complex to study the cisplatin-induced activation of ERK1/2 and inhibition of cisplatin-induced ERK1/2 activity by PD98059 [ncbi , more ].
  • western blotAna Artero-Castro et al. utilized Santa Cruz Biotechnology ERK1 antibody to demonstrate that Cold-Inducible RNA-Binding Protein bypassed replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation [ncbi , more ] in 2009 and Yi Xie et al. used Santa Cruz Biotechnology ERK1 antibody to perform western blot in order to study the affect of the S-glutathionylation of STAT3 [ncbi , more ]. In 2008, H Agis et al. used Santa Cruz Biotechnology ERK1 antibody to perform western blot in order to show that periodontal ligament fibroblasts can maintain an equilibrium of the plasminogen activator system in the presence of platelet-derived growth factor isoforms [ncbi , more ]. Santa Cruz Biotechnology ERK1 antibody was applied in 2006 to study the role for the interaction of DUSP26 with Hsf4b in the MAP kinase signaling pathway in human lung carcinoma cell line H1299 [ncbi , more ], to study the effect of advanced glycation end products on chymase-dependent angiotensin II generating pathway in diabetic complications [ncbi , more ], to study the role for anaplastic lymphoma kinase activity in proliferation and survival of anaplastic large-cell lymphoma cells [ncbi , more ]and to study the expression of EG-VEGF/PK1 and PK2 and their receptors (PK-R1 and PK-R2) in human prostate and their involvement in cancer [ncbi , more ]. Santa Cruz Biotechnology ERK1 antibody was employed in 2005 to study the induction of neuroblastoma cell apoptosis by TrkA [ncbi , more ], to study the role of uPAR in cross-talk between FPR and alphavbeta5 [ncbi , more ], to study ERK2 and p38 involvement in platelet adhesion to collagen [ncbi , more ], to study the effect of enhanced p38 MAPK activity on endothelial cell function [ncbi , more ], to study epidermal growth factor-induced corneal epithelial cell proliferation [ncbi , more ]and to study a novel link between GILZ and regulation of epithelial sodium transport through modulation of ERK signaling [ncbi , more ]. Santa Cruz Biotechnology ERK1 antibody was utilized in 2004 to evaluate therapeutic potential of the combination of IGFBP-3 and SCH66336 [ncbi , more ], to study the physical interaction between Runx2 and Stat3beta enhanced by GH and downregulateing the transcriptional properties of this key osteogenic regulator (catalog: sc-7383) [ncbi , more ], to study the requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis [ncbi , more ], to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ], to detect extracellular signal-regulated kinase 1 in Panc-1 cells [ncbi , more ], to detect the phospho-p44 MAPK in differentiated and non-differentiated N1E-115-NT1-EGFP cells stimulated with no agonist or JMV 449 [ncbi , more ], to study a New Negative Regulator of A-Raf Kinase, trihydrophobin 1 [ncbi , more ], to detect Erk1 in neutrophils isolated from citrated blood of healthy single donors [ncbi , more ]and to study the function of tumor suppressor CYLD in the regulation of JNK signaling [ncbi , more ]. Santa Cruz Biotechnology ERK1 antibody was used in 2003 to demonstrate that ERK1/2 are the Raf effectors for suppression of integrin activation [ncbi , more ], to study the interaction of calcium/calmodulin-dependent protein kinase II with Raf-1 and the effect of it on integrin-stimulated ERK activation [ncbi , more ], to study the role of v-SRC to specifically regulate the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6) (catalog: sc-93) [ncbi , more ], to investigate the activation of ERK1/2 in primary human melanocytes isolated from neonatal foreskins and in the human melanoma SK-MEL-24 and SK-MEL-28 cell lines [ncbi , more ], to study the function of pancreatic bile salt-dependent lipase to induce smooth muscle cells proliferation [ncbi , more ], to study the effect of leukocyte-endothelium interaction on SDF-1-dependent polarization of CXCR4 [ncbi , more ], to study the role for the p27Kip1 inhibition of GRB2-SOS formation in regulating Ras activation [ncbi , more ], to identify two substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5 [ncbi , more ], to investigate the effects of CNTF on fat cells [ncbi , more ]and to detect the protein levels of Erk-1 in human Jurkat E6-1 T cells [ncbi , more ]. Santa Cruz Biotechnology ERK1 antibody was used in 2002 to study the role of SAP in murine CD150 (SLAM) mediated T-cell proliferation and interferon gamma production [ncbi , more ], to study the role for the interaction between G protein-coupled receptor and the phosphatase SHP-2 in bradykinin-induced inhibition of cell proliferation [ncbi , more ], to detect ERK1/2 in A2780 and OVCAR5 ovarian cancer cell lines and human HEK293 cells [ncbi , more ], to study the regulation of the phosphorylation of MAP kinases by UVB [ncbi , more ], to study the expression and kinase activity of ERKs [ncbi , more ], to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET [ncbi , more ], to study the regulatory role of protein kinase A anchoring protein (AKAP) related protein in the modulation of SPHK1 activity in human HEK 293 cells [ncbi , more ], to study the role of Rac1 in M3 mAChR-dependent signaling [ncbi , more ], to detect total and phospho-ERK1 in human B lymphoma cell line ramos 2G6 incubated with anti-CD45, following stimulation by IL-4 and anti-CD40 [ncbi , more ], to detect ERK1 in D5 and vector HEK293 cells untreated or treated with insulin [ncbi , more ], to detect ERK1 in A549 cells [ncbi , more ], to study the ability of lead to activate the MAPK cascade and the role of PKC in this signal transduction pathway [ncbi , more ]and to study the role for MAP kinase and beta-catenin signaling in HGF induced RPE migration in human ARPE-19 cells and RPE cells [ncbi , more ]. In 2001, S Elowe et al. utilized Santa Cruz Biotechnology ERK1 antibody to study the downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase [ncbi , more ]. In 2000, D L Persons et al. employed Santa Cruz Biotechnology ERK1 antibody to precipitate ERK1/2 complex to study the cisplatin-induced activation of ERK1/2 and inhibition of cisplatin-induced ERK1/2 activity by PD98059 [ncbi , more ].
Cell Signaling TechnologyCell Signaling Technology ERK1 product
  • flow cytometryIn 2003, Jeroen P Roose et al. applied Cell Signaling Technology ERK1 antibody to detect the protein levels of phosphorylated Erk-1, and in flow cytometry to analyze for phospho-p44/42 MAP kinase (Thr204/Tyr204) in human Jurkat E6-1 T cells [ncbi , more ].
  • immunocytochemistryIn 2001, J Albanell et al. utilized Cell Signaling Technology ERK1 antibody to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ].
  • immunohistochemistryIn 2008, Linda Yu et al. used Cell Signaling Technology ERK1 antibody to study the role for expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in mediating uterine leiomyoma growth in sections from human tissue [ncbi , more ]. In 2006, Nabeel Bardeesy et al. utilized Cell Signaling Technology ERK1 antibody to perform mmunohistochemistry assays in order to investigate the molecular regulation mechanisms of Smad4 in the process of normal pancreas development and pancreatic ductal adenocarcinomas (PDAC) growth [ncbi , more ]. In 2004, Timothy J King et al. employed Cell Signaling Technology ERK1 antibody to study the role of Cx32/GJIC in radiation-induced tumorigenesis of the liver [ncbi , more ]. In 2001, J Albanell et al. utilized Cell Signaling Technology ERK1 antibody to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ].
  • immunoprecipitationCell Signaling Technology ERK1 antibody was applied in 2009 to demonstrate that oncogenic K-Ras can increase proliferation and decrease cell junctions [ncbi , more ], to perform to western blot and immunoprecipitation in order to study the role of ALK in the pathogenesis and the treatment of anaplastic large cell lymphoma [ncbi , more ]and to study the role of Beclin 1 in the regulation of autophagy [ncbi , more ]. In 2007, Sridevi Yadavilli et al. used Cell Signaling Technology ERK1 antibody to carry out western blot analysis and immunoprecipitation assays in order to investigate the role for human ribosomal protein S3 in the reuglation of DNA damage recognition [ncbi , more ]. In 2002, John K G Crean et al. utilized Cell Signaling Technology ERK1 antibody to study the role of p42/44 MAPK and protein kinase B in CTGF induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells [ncbi , more ].
  • western blotIn 2013, Jean Luc Montillet et al. used Cell Signaling Technology ERK1 antibody to perform western blot to study the role of the abscisic acid-independent oxylipin pathway in controlling stomatal closure and immune defense in Arabidopsis [ncbi , more ]. Cell Signaling Technology ERK1 antibody was used in 2010 to perform western blot in order to study the mechanism by which Angiotensin-(1-7) inhibited CAF growth and reduced tumour fibrosis in orthotopic breast tumors [ncbi , more ], to perform western blot in order to show the role of cyclin K and cyclin D1b in multiple myeloma [ncbi , more ], to study the role of activated state of p42/44 and p38 in MMP-13 expression [ncbi , more ], to investigate the role of beta-catenin in the regulation of Kras dependent reprogramming of acini into PDA preneoplastic precursors in mice [ncbi , more ], to investigate the role of PKCdelta in the regulation of CHL1 expression in cultured astrocytes. [ncbi , more ]and to perform western blot in order to study the role of PRL-2 in breast cancer formation and progression [ncbi , more ]. Cell Signaling Technology ERK1 antibody was used in 2009 to perform western blot in order to study the important role of GRK4 in D3 receptor's signaling in human proximal tubule cells [ncbi , more ], to study the role of Beclin 1 in the regulation of autophagy [ncbi , more ], to investigate the role of sproutys in the regulation angiogenesis and ischemia in mice [ncbi , more ], to demonstrate that BCL6 interacts with HB-EGF-CTF and that this interaction might induce the cyclin D2 expression in human gastric cancer [ncbi , more ], to identify Pak4 as a novel Gab1-interacting protein downstream from the Met receptor and to study its function [ncbi , more ], to perform western blot in order to investigate the molecular mechanisms underlying CRMP2 function in CXCL12-induced T lymphocyte migration [ncbi , more ], to carry out immunoblotting assays in order to investigate the mechanism of ERK-dependent transactivation of the EGFR by G protein-dependent and beta-arrestin-dependent pathways in vascular smooth muscle cells [ncbi , more ], to perform immunoblotting in order to study the regulation of BAD phosphorylation involved in beta-arrestin-2 mediated anti-apoptotic effects [ncbi , more ], to perform western blot in order to show that rapamycin treatment can lead to the transactivation of the EGFR [ncbi , more ], to carry out western blot analysis in order to investigate whether Klebsiella pneumoniae could upregulate the expression of Toll-like receptors in human airway epithelial cells [ncbi , more ], to carry out western blot analysis in order to investigate whether FGFR4 plays a role in promoting the progression of hepatocellular carcinoma [ncbi , more ], to perform to western blot and immunoprecipitation in order to study the role of ALK in the pathogenesis and the treatment of anaplastic large cell lymphoma [ncbi , more ], to carry out western blot analysis in order to investigate the role for the stereochemistry of beta2-adrenoceptor agonist fenoterol in determining receptor-G protein selectivity and downstream signaling [ncbi , more ]and to characterize the role of ERBB4 mutations in melanoma [ncbi , more ]. Cell Signaling Technology ERK1 antibody was used in 2008 to demonstrate that IL-19 can be induced by inflammatory cytokines and inflammatory stimuli [ncbi , more ], to identify the pathway and mechanism by which AAs signal to hVps34 to stimulate mTOR complex1 signaling [ncbi , more ], to study the role for the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor [ncbi , more ], to study the role for expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in mediating uterine leiomyoma growth in sections from human tissue [ncbi , more ], to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ], to study the role of the VLDLR in inhibiting cell division [ncbi , more ]and to ascertain whether the downstream signaling pathways mediated by TGF-beta vary in different liver injury models [ncbi , more ]. Cell Signaling Technology ERK1 antibody was utilized in 2007 to carry out western blot analysis and immunoprecipitation assays in order to investigate the role for human ribosomal protein S3 in the reuglation of DNA damage recognition [ncbi , more ], to phosphorylated ERK1/2 in platelets from patients during AMI [ncbi , more ], to demonstrate that leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells [ncbi , more ]and to study the role of glycosylation in the NK1R in human colonic epithelial cell line [ncbi , more ]. Cell Signaling Technology ERK1 antibody was employed in 2006 to study the role for the effect of H-REV107-1 on mitogenic signaling in growth in human non-small cell lung carcinomas [ncbi , more ], to investigate the activation of ERK1/2 by FGF19 promoter in human CE cells [ncbi , more ], to study the role for the effect of receptor tyrosine kinase on lymphatic endothelial cells in therapy of colon cancer lymph node metastasis [ncbi , more ], to detect phosphorylated ERK protein in human HT-29 colon cells [ncbi , more ], to study inhibition of MAPK and NFkappaB signaling pathways through preventing activation of the family of MAPK kinases (MAPKK) [ncbi , more ], to analyze biology and drug responsiveness of human breast cancer [ncbi , more ], to study the role for E3 ubiquitin ligase dorfin in calcium-sensing receptor ubiquitination and degradation [ncbi , more ], to detect Erk1 and phosphorylated Erk1 in human HeLa cells [ncbi , more ], to detect the phosphorylation of p42/44 MAPK in primary neonatal human melanocytes [ncbi , more ], to detect ERK and activation of ERK in human renal carcinoma ACHN cells [ncbi , more ]and to examine ERK1/2 phosphorylation in human breast cancer cell lines MDA-MB231 and MCF-7 [ncbi , more ]. Cell Signaling Technology ERK1 antibody was utilized in 2005 to study a novel link between GILZ and regulation of epithelial sodium transport through modulation of ERK signaling [ncbi , more ], to study the role of 2'-5'-oligoadenylate activation of RNase L for transcriptional signaling pathway in the IFN system [ncbi , more ], to study the effect of the interaction between histone deacetylase inhibitors and protein phosphatase 1 complexes on Akt in human U87MG cells [ncbi , more ], to study the function of protein phosphatase subunit G5PR in B cell receptor induced apoptosis [ncbi , more ], to detect phospho-p44 MAPK in HT-29 cells treated with NMT1-1 siRNA or NMT2-4 siRNA [ncbi , more ], to investigate regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation [ncbi , more ], to study the changes of retinal gene expression in proliferative vitreoretinopathy [ncbi , more ], to investigate the down-regulation of phospholipase D2 in the EWS-Fli1-knocked down TC-135 cells [ncbi , more ], to study the direct interaction between human CNK1 and Raf-1 [ncbi , more ], to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro [ncbi , more ], to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury [ncbi , more ], to study the interaction of tis21 protein with Pin-1 after phosphorylation of its Ser147 residue by p-Erk1/2 [ncbi , more ], to study the regulation of inducible cyclooxygenase-2 and prostaglandin E2 synthesis by Clostridium difficile toxin A via reactive oxygen species and activation of p38 MAPK [ncbi , more ], to study the inhibitory effects of galanin receptor 1 on proliferation in oral squamous cell carcinoma [ncbi , more ], to study the function of the mitogen-activated protein kinase kinase kinase DLK as a key regulator of keratinocyte terminal differentiation [ncbi , more ], to study the effect of signal transducers and activators of transcription 3 on the transcriptional activity of CCAAT/enhancer-binding protein beta in granulocyte colony-stimulating factor signaling pathway [ncbi , more ], to study the central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptors [ncbi , more ], to study the effect of ERK kinase inhibition on the Aryl hydrocarbon receptor [ncbi , more ]and to detect phospho-ERK1 in PAK4 knockdown (RNAi) cells untreated or treated with TNFalpha+CHX [ncbi , more ]. Cell Signaling Technology ERK1 antibody was applied in 2004 to examine the levels of ERK1/ERK2 in human melanoma cell line A375 [ncbi , more ], to study the function of Gs-coupled receptors to induce activation of H-Ras and the ERK1/2 MAP kinases by an Epac- and Ca2+-controlled pathway [ncbi , more ], to detect Erk1 and phospho-Erk1 in human coronary artery endothelial cells (HCAEC) treated with VEGF or HGF [ncbi , more ], to study the effects of LAQ824 and/or PKC412 on the levels of mutant FLT-3 and its downstream signaling, as well as growth arrest and cell-death of cultured and primary human AML cells [ncbi , more ], to detect phospho-p44MAPK in NIH 3T3 cells transiently transfected with vector, RACK1, or mutant RACK1, and HEK 293 cells transfected with RACK1 siRNAs [ncbi , more ], to detect phospho-Erk1 in HeLa cells with FTI treatment [ncbi , more ], to detect phospho-ERK1 in human differentiated myotubes stimulated with insulin [ncbi , more ], to detect Akt and phospho-Akt in ET-1-treated lung fibroblasts from open lung biopsy specimens from SSc patients [ncbi , more ], to detect the presence of phosphorylated MAPK in porcine aortic endothelial (PAE) cells [ncbi , more ], to detect ERK1 and phospho-ERK1 in human ejaculate spermatozoa [ncbi , more ], to detect phospho-p44 ERK in NR6 WT cells and NR6 c'973 cells [ncbi , more ], to study the role of PTEN in PDGF-induced DNA synthesis [ncbi , more ], to detect phospho-p44 MAPK in rat cardiac myocytes infected with recombinant adenoviruses containing human wild type or mutant cDNA of RasGAP, Akt or ILK [ncbi , more ], to detect phospho-ERK1 in 3T3-L1 cells infected with a retrovirus carrying the gene for C/EBPalpha [ncbi , more ], to study the role of Rip2 in Bcl10 signaling and T-cell receptor-mediated NF- B activation [ncbi , more ], to study the regulation of TFPI-2 expression by thrombin [ncbi , more ], to study the role for the sema domain of RON in ligand binding by the full-length receptor [ncbi , more ], to detect phospho-Erk in neutrophils isolated from citrated blood of healthy single donors [ncbi , more ]and to study the effect of peptide spanning the A strand of the proto-oncogene TCL1 on Akt kinase activity [ncbi , more ]. Cell Signaling Technology ERK1 antibody was applied in 2003 to study the inhibition of lysophosphatidic acid acyltransferase beta on proliferative and survival signals in normal cells and apoptosis of tumor cells [ncbi , more ], to study the roles of Janus kinase 2 and calcium for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells [ncbi , more ], to study the role of tyrosine phosphorylation in Reelin-stimulated activation of Akt and Src family kinases [ncbi , more ], to detect p44 MAPK and phopho-p44 MAPK in SK-LMS-1 cells and MDA-MB-231 cells with human TSP1 transfection [ncbi , more ], to study the Initiation of CD38 signaling in T Cells within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor [ncbi , more ], to detect P44 MAPK and phospho-P44 MAPK in fibroblasts containing wild type Cas, CasY253F, or Cas118423 [ncbi , more ], to study regulation of monocyte matrix metalloproteinase-1 and 9 by interferon-gamma [ncbi , more ], to detect ERK and phospho-ERK in CHO cell expressing the IR and IRS-1 transfected with MOR [ncbi , more ], to detect ERK1 and phospho-ERK1 in baculovirus infected with different versions of human Itk [ncbi , more ], to investigate the activation of ERK1/2 in primary human melanocytes isolated from neonatal foreskins and in the human melanoma SK-MEL-24 and SK-MEL-28 cell lines [ncbi , more ], to detect ERK1 and phospho-ERK1 in mutant and normal lymphocytes from patients [ncbi , more ], to study the interaction of Bcr kinase and AF-6 and the effects of them on Ras signaling [ncbi , more ], to study the regulation of the biological effects of TWEAK [ncbi , more ], to study the GIPC interaction with beta1-adrenergic receptor and its regulation on beta1-adrenergic receptor-mediated ERK activation [ncbi , more ], to study lysophosphatidic acid-coupled LPA1/EDG-2 receptors endocytosis [ncbi , more ], to study that resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells [ncbi , more ], to study the role of Raf-1 and Bcl-2 in breast cancer drug resistance [ncbi , more ], to identify a putative G protein-coupled receptors (GPCR) as an intermediary in meiotic maturation of fish oocytes [ncbi , more ], to investigate the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway mediated by Kaposi's sarcoma-associated herpesvirus early during infection of target cells [ncbi , more ], to study the role of DOC-2/DAB2 of c-Src in normal prostatic epithelium and cancer [ncbi , more ]and to detect the protein levels of phosphorylated Erk-1, and in flow cytometry to analyze for phospho-p44/42 MAP kinase (Thr204/Tyr204) in human Jurkat E6-1 T cells [ncbi , more ]. Cell Signaling Technology ERK1 antibody was utilized in 2002 to investigate the phosphorylation of ERK1/2 in human microvascular endothelial cells isolated by enzymatic digestion of blood vessels taken from the mesentery of the small bowel (designated MM1 cells) [ncbi , more ], to study the regulation and the functional consequences after the extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease [ncbi , more ], to study the role of p42/44 MAPK and protein kinase B in CTGF induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells [ncbi , more ], to study the significance of the dimerization function associated with the BTB/POZ domain of Keap1 for sequestration of Nrf2 in the cytoplasm [ncbi , more ], to study the biological characteristics of insulin/insulin-like growth factor I hybrid receptors [ncbi , more ], to examine the levels of activated ERK in A2780 and OVCAR5 ovarian cancer cell lines and human HEK293 cells [ncbi , more ], to study the phosphorylation of several members of the MAPK pathways [ncbi , more ], to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET [ncbi , more ], to detect phosphorylated p44 MAPK in chlorate-treated Rama 27 fibroblasts [ncbi , more ], to study the role of CD147 as a cell surface receptor for CyPA and an essential component in the CyPA-initiated signaling cascade that culminates in ERK activation [ncbi , more ], to detect Erk-1 in HUVEC [ncbi , more ], to detect phospho-ERK1 in D5 and vector HEK293 cells untreated or treated with insulin [ncbi , more ], to study attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse [ncbi , more ], to detect phospho-ERK1 in A549 cells [ncbi , more ], to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas [ncbi , more ], to study the role for ANGPTL3 in endothelial cell adhesion and migration and blood vessel formation in Vivo in human cells [ncbi , more ], to study the biological function of nerve growth factor in the regulation of dopamine D2 receptor expression [ncbi , more ], to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells [ncbi , more ], to study the relationship of activation of signal transducer and activator of transcription 1 (STAT1) and IFN with induction of STAT1-dependent genes in endothelial cells [ncbi , more ]and to exploit EphA2 as a therapeutic target of cancer [ncbi , more ]. Cell Signaling Technology ERK1 antibody was employed in 2001 to study the downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase [ncbi , more ], to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ], to study the relationship between UCN-01 actions and activity of the MAPK pathway [ncbi , more ], to study the regulation of Ca2+/Calmodulin-dependent eNOS activity by the phosphorylation of eNOS Thr495 [ncbi , more ], to identify a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-Cell receptor-mediated activation of PLC-1 and NFAT [ncbi , more ], to study the role of filamin-A in participating in CaR-mediated activation of mitogen-activated protein kinaseas by binding to the CaR's carboxyl-terminal tail [ncbi , more ], to investigate the inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade [ncbi , more ], to study the transcriptional program induced by Raf in epithelial cells [ncbi , more ], to study growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors [ncbi , more ], to study the mechanisms of silica carcinogen on pulmonary epithelial cells [ncbi , more ], to investigate erythropoietin effect on neuronal apoptosis after cerebral ischemia and metabolic stress [ncbi , more ], to study opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite [ncbi , more ], to study the role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt [ncbi , more ], to study borna disease virus persistent infection in the central nervous system [ncbi , more ]and to detect phospho-ERK1 in NIH-3T3 fibroblasts transfected with expression vector for GFP and C-terminal-truncated STAT3 [ncbi , more ].
EMD MilliporeEMD Millipore ERK1 product
  • western blotSeungkirl Ahn et al. utilized EMD Millipore ERK1 antibody to perform immunoblotting in order to study the regulation of BAD phosphorylation involved in beta-arrestin-2 mediated anti-apoptotic effects [ncbi , more ] in 2009 and D Chaturvedi et al. used EMD Millipore ERK1 antibody to perform western blot in order to show that rapamycin treatment can lead to the transactivation of the EGFR [ncbi , more ]. In 2008, Elena S Suvorova et al. utilized EMD Millipore ERK1 antibody to study the role for the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor [ncbi , more ]. In 2007, Hannah Murdoch et al. applied EMD Millipore ERK1 antibody to determine whether the PDE4 sequestered by DISC1 is released after cAMP elevation [ncbi , more ]. In 2006, Sylwia Ammoun et al. employed EMD Millipore ERK1 antibody to study the role of G-protein-coupled receptor signaling in cell death via p38 mitogen-/stress-activated protein kinase independent of p53 and caspase activation [ncbi , more ]. In 2004, Mireille Toy-Miou-Leong et al. employed EMD Millipore ERK1 antibody to detect the total p44 MAPK in differentiated and non-differentiated N1E-115-NT1-EGFP cells stimulated with no agonist or JMV 449 [ncbi , more ]. In 2003, DiAnna L Hynds et al. employed EMD Millipore ERK1 antibody to study the role of Rit in human neuroblastoma cells for MEK-independent neurite branching [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation ERK1 product
  • immunocytochemistryIn 2003, Sean R Conner et al. employed Life Technologies Corporation ERK1 antibody to detect the localization of activated ERK1/2 in human melanoma SK-MEL-28 cells [ncbi , more ].
  • western blotAlexandra Mazharian et al. used Life Technologies Corporation ERK1 antibody to study ERK2 and p38 involvement in platelet adhesion to collagen [ncbi , more ] in 2005 and Nicholas E Vlahakis et al. used Life Technologies Corporation ERK1 antibody to characterize lymphangiogenic vascular endothelial growth factors VEGF-C and D [ncbi , more ]. In 2004, Susana Castro-Obregon et al. employed Life Technologies Corporation ERK1 antibody to study SP/NK1R-induced cell death mediated by a MAP kinase activation pathway involving Raf-1, MEK2, and extracellular signal-regulated protein kinase 2 (ERK2) [ncbi , more ]. In 2001, D Yablonski et al. used Life Technologies Corporation ERK1 antibody to identify a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-Cell receptor-mediated activation of PLC-1 and NFAT [ncbi , more ].
R and D SystemsR and D Systems ERK1 product
  • western blotIn 2009, Emma E Frost et al. used R and D Systems ERK1 antibody to carry out western blot analysis in order to investigate the role for PDGF-A activated ERK signaling pathway in the regulation of oligodendrocyte progenitor cell migration [ncbi , more ]. In 2005, Zhi Sheng et al. utilized R and D Systems ERK1 antibody to study rRNA transcription regulation by fibroblast growth factor 2 [ncbi , more ].
EpitomicsEpitomics ERK1 product
  • western blotIn 2008, Al Karim Khimji et al. used Epitomics ERK1 antibody to ascertain whether the downstream signaling pathways mediated by TGF-beta vary in different liver injury models [ncbi , more ].
Enzo Life Sciences
  • western blotIn 2002, Catherine Lavoie et al. employed Enzo Life Sciences ERK1 antibody to study the regulation of heterodimerization beta1/beta2-adrenergic receptor for beta2-adrenergic receptor internalization and ERK signaling efficacy [ncbi , more ].
Novus Biologicals
  • western blotIn 2008, Kaili Mao et al. employed Novus Biologicals ERK1 antibody to perform Western blotting assays in order to study the molecular mechanisms of C-reactive protein in inhibiting cholesterol efflux from human foam cells [ncbi , more ].
BD Biosciences
  • immunocytochemistryIn 2004, Zhibo Yang et al. used BD Biosciences ERK1 antibody to study estrogen receptor alpha modulation in breast cancer cells [ncbi , more ].
  • western blotIn 2009, Lingyun Zhu et al. used BD Biosciences ERK1 antibody to examine the role of PGC-1alpha in vascular smooth muscle cell function [ncbi , more ]. In 2008, Mino Yoshioka et al. utilized BD Biosciences ERK1 antibody to study the role for human cathelicidin CAP18/LL-37 in changing mast cell function in LAD2 human mast cell line [ncbi , more ]. In 2006, F E Utama et al. used BD Biosciences ERK1 antibody to analyze biology and drug responsiveness of human breast cancer [ncbi , more ]. BD Biosciences ERK1 antibody was applied in 2005 to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury [ncbi , more ], to study HER-2 down-regulation in colon cancer cells [ncbi , more ], to detect ERK-1 as a loading control in articular chondrocytes treated with the indicated concentrations of Wnt-7a-conditioned medium, LiCl, or interleukin-1beta [ncbi , more ], to study the biological function of 15 (S) hydroxyeicosatetraenoic acid in PKCaplpha translocation [ncbi , more ]and to study SHPS-1 in the regulation of insulin-like growth factor I which stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells [ncbi , more ]. Zhibo Yang et al. used BD Biosciences ERK1 antibody to study estrogen receptor alpha modulation in breast cancer cells [ncbi , more ] in 2004 and Debora Angeloni et al. used BD Biosciences ERK1 antibody to study the role for the sema domain of RON in ligand binding by the full-length receptor [ncbi , more ]. In 2003, Toru Furukawa et al. used BD Biosciences ERK1 antibody to identify DUSP6 as one of the key players in the tumor suppressive pathway and as a promising molecular target for curing patients with pancreatic cancer [ncbi , more ]. In 2002, Dong Xiao et al. employed BD Biosciences ERK1 antibody to study the expression and kinase activity of ERKs [ncbi , more ]. In 2001, S Elowe et al. utilized BD Biosciences ERK1 antibody to study the downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase [ncbi , more ].
Sigma-AldrichSigma-Aldrich ERK1 product
  • western blotSelwyn A Williams et al. used Sigma-Aldrich ERK1 antibody to demonstrate that fibulin-1 inhibits fibroblast spreading and cell-mediated contraction of a fibrin-FN matrix [ncbi , more ] in 2009 and Emma E Frost et al. used Sigma-Aldrich ERK1 antibody to carry out western blot analysis in order to investigate the role for PDGF-A activated ERK signaling pathway in the regulation of oligodendrocyte progenitor cell migration [ncbi , more ]. In 2006, Alessandra Spaziani et al. employed Sigma-Aldrich ERK1 antibody to detect ERK1 and activated-ERK1 in total cell extracts from HCV core-positive HepG2 cells transfected or not with siRNA core [ncbi , more ]. Sigma-Aldrich ERK1 antibody was used in 2005 to study the inducing of platelet-derived growth factor C to liver fibrosis, steatosis, and hepatocellular carcinoma [ncbi , more ], to study the MMP-1 expression downregulation by Cdc42 inhibiting the ERK1/2 pathway [ncbi , more ]and to study the function of protein phosphatase subunit G5PR in B cell receptor induced apoptosis [ncbi , more ]. In 2003, Toru Furukawa et al. used Sigma-Aldrich ERK1 antibody to identify DUSP6 as one of the key players in the tumor suppressive pathway and as a promising molecular target for curing patients with pancreatic cancer [ncbi , more ]. In 2001, A Hans et al. employed Sigma-Aldrich ERK1 antibody to study borna disease virus persistent infection in the central nervous system [ncbi , more ].
Promega
  • western blotYingfeng Qiao et al. used Promega ERK1 antibody to study the protein tyrosine kinase Src R388A mutant rescued in live cells with the use of the small molecule imidazole [ncbi , more ] in 2006 and Sylwia Ammoun et al. used Promega ERK1 antibody to study the role of G-protein-coupled receptor signaling in cell death via p38 mitogen-/stress-activated protein kinase independent of p53 and caspase activation [ncbi , more ]. Nichole Boyer Arnold et al. applied Promega ERK1 antibody to study COLO-357 cell growth inhibition by TGF beta1 [ncbi , more ] in 2005 and Bradley S Henson et al. used Promega ERK1 antibody to study the inhibitory effects of galanin receptor 1 on proliferation in oral squamous cell carcinoma [ncbi , more ]. Promega ERK1 antibody was employed in 2004 to detect total and phosphorylated p42/p44 MAPKs in primary human foreskin fibroblasts [ncbi , more ], to detect the phospho-extracellular signal-regulated kinase 1 in Panc-1 cells [ncbi , more ], to detect ERK1 in 3T3-L1 cells infected with a retrovirus carrying the gene for C/EBPalpha [ncbi , more ], to study the regulation of TFPI-2 expression by thrombin [ncbi , more ]and to study the role of KSR1 in regulating intestinal cell fate during cytokine-mediated inflammation [ncbi , more ]. In 2003, Sanjin Zvonic et al. utilized Promega ERK1 antibody to investigate the effects of CNTF on fat cells [ncbi , more ]. Promega ERK1 antibody was employed in 2002 to study leukotriene biosynthesis in human neutrophils [ncbi , more ], to study the ability of lead to activate the MAPK cascade and the role of PKC in this signal transduction pathway [ncbi , more ], to study insulin receptor catalytic activity inhibition [ncbi , more ]and to study the role for the interaction between G protein-coupled receptor and the phosphatase SHP-2 in bradykinin-induced inhibition of cell proliferation [ncbi , more ]. L You et al. used Promega ERK1 antibody to study migration and signal transduction in corneal epithelial cells [ncbi , more ] in 2001 and C C Chen et al. used Promega ERK1 antibody to study the induction of adhesive signaling in primary human skin fibroblasts [ncbi , more ].
Articles Reviewed
  1. Jean Luc Montillet et al. (2013). "An abscisic acid-independent oxylipin pathway controls stomatal closure and immune defense in Arabidopsis".PMID 23526882
  2. Serge Hardy et al. (2010). "Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression".PMID 20841483
  3. Katherine L Cook et al. (2010). "Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors".PMID 20837666
  4. Veronique Marsaud et al. (2010). "Cyclin K and cyclin D1b are oncogenic in myeloma cells".PMID 20459741
  5. Nelli Ziegler et al. (2010). "Mechano-transduction in periodontal ligament cells identifies activated states of MAP-kinases p42/44 and p38-stress kinase as a mechanism for MMP-13 expression".PMID 20109185
  6. John P Morris et al. (2010). "Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice".PMID 20071774
  7. Todd D Prickett et al. (2009). "Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4".PMID 19718025
  8. Junfang Wu et al. (2010). "Phosphatidylinositol 3-kinase/protein kinase Cdelta activation induces close homolog of adhesion molecule L1 (CHL1) expression in cultured astrocytes".PMID 19672967
  9. Van Anthony M Villar et al. (2009). "G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor".PMID 19520868
  10. Jianrong Wang et al. (2009). "A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1".PMID 19520853
  11. Koji Taniguchi et al. (2009). "Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis".PMID 19424491
  12. Y Hirata et al. (2009). "BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers".PMID 19337254
  13. Grigorios N Paliouras et al. (2009). "Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor".PMID 19289496
  14. Michel Varrin-Doyer et al. (2009). "Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration".PMID 19276087
  15. Jihee Kim et al. (2009). "Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor".PMID 19254952
  16. Seungkirl Ahn et al. (2009). "{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation".PMID 19171933
  17. Ana Artero-Castro et al. (2009). "Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation".PMID 19158277
  18. D Chaturvedi et al. (2009). "Rapamycin induces transactivation of the EGFR and increases cell survival".PMID 19151764
  19. Lingyun Zhu et al. (2009). "PGC-1alpha is a key regulator of glucose-induced proliferation and migration in vascular smooth muscle cells".PMID 19142226
  20. Berta Casar et al. (2009). "Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins".PMID 19114553
  21. Selwyn A Williams et al. (2009). "A shared mechanism of adhesion modulation for tenascin-C and fibulin-1".PMID 19109427
  22. Xue Qing Wang et al. (2009). "Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9".PMID 19037103
  23. Verónica Regueiro et al. (2009). "Klebsiella pneumoniae increases the levels of Toll-like receptors 2 and 4 in human airway epithelial cells".PMID 19015258
  24. Xinqiang Huang et al. (2009). "Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis".PMID 19009564
  25. Yi Xie et al. (2009). "S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling".PMID 18988672
  26. Francesco E Boccalatte et al. (2009). "The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL".PMID 18845790
  27. Anthony Yiu Ho Woo et al. (2009). "Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes".PMID 18838481
  28. Al Karim Khimji et al. (2008). "Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation".PMID 18753413
  29. Ying Tian et al. (2008). "Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia".PMID 18669613
  30. Emma E Frost et al. (2009). "Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway".PMID 18512152
  31. Pawan Gulati et al. (2008). "Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34".PMID 18460336
  32. H Agis et al. (2008). "Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts".PMID 18447857
  33. Elena S Suvorova et al. (2008). "Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor".PMID 18346468
  34. Mino Yoshioka et al. (2008). "Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity".PMID 18239275
  35. Linda Yu et al. (2008). "Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas".PMID 18231572
  36. Emily J Faivre et al. (2008). "Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors".PMID 18202149
  37. Kaili Mao et al. (2008). "The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy".PMID 18097592
  38. Anush Oganesian et al. (2008). "Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells".PMID 18032585
  39. Hannah Murdoch et al. (2007). "Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels".PMID 17728464
  40. Morris F Tansky et al. (2007). "Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor".PMID 17563389
  41. Sridevi Yadavilli et al. (2007). "Translocation of human ribosomal protein S3 to sites of DNA damage is dependant on ERK-mediated phosphorylation following genotoxic stress".PMID 17560175
  42. Arantxa Ortega et al. (2007). "Effect of parathyroid-hormone-related protein on human platelet activation".PMID 17501718
  43. M R Hoda et al. (2007). "Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells".PMID 17212381
  44. Nabeel Bardeesy et al. (2006). "Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer".PMID 17114584
  45. Yoko Mitsui et al. (2006). "ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3".PMID 17047053
  46. Irina Nazarenko et al. (2006). "H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling".PMID 17003497
  47. Yahya Tamimi et al. (2006). "FGF19 is a target for FOXC1 regulation in ciliary body-derived cells".PMID 17000708
  48. Robert B Rebhun et al. (2006). "Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis".PMID 16984732
  49. Jürgen Schauber et al. (2006). "Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli".PMID 16895558
  50. Daniela Pasquali et al. (2006). "The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy".PMID 16763065
  51. Sohini Mukherjee et al. (2006). "Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation".PMID 16728640
  52. Yanzhong Hu et al. (2006). "Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26".PMID 16581800
  53. F E Utama et al. (2006). "Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice".PMID 16522738
  54. Vijay Koka et al. (2006). "Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications".PMID 16520412
  55. Yingfeng Qiao et al. (2006). "Chemical rescue of a mutant enzyme in living cells".PMID 16513984
  56. Ying Huang et al. (2006). "Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin".PMID 16513638
  57. Fred B Berry et al. (2006). "Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-activated mitogen-activated protein kinase signaling cascade".PMID 16492674
  58. Gael G McGill et al. (2006). "c-Met expression is regulated by Mitf in the melanocyte lineage".PMID 16455654
  59. Alessandra Spaziani et al. (2006). "Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1".PMID 16446363
  60. Seiji Ueno et al. (2006). "Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility".PMID 16428383
  61. Sylwia Ammoun et al. (2006). "G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase".PMID 16282319
  62. Weihua Wan et al. (2006). "Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells".PMID 16254137
  63. Xiaofan Li et al. (2005). "PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor".PMID 16227624
  64. Zhi Sheng et al. (2005). "Direct regulation of rRNA transcription by fibroblast growth factor 2".PMID 16227592
  65. Rama Soundararajan et al. (2005). "A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport".PMID 16216878
  66. Krishnamurthy Malathi et al. (2005). "A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L".PMID 16203993
  67. Chang Shi Chen et al. (2005). "Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes".PMID 16186112
  68. Yan Xing et al. (2005). "Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis".PMID 16129705
  69. Charles E Ducker et al. (2005). "Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis".PMID 16123142
  70. Guillaume Bossis et al. (2005). "Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation".PMID 16055710
  71. Margrit Hollborn et al. (2005). "Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF".PMID 15988409
  72. Jean Francois Lavoie et al. (2005). "TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism".PMID 15961390
  73. Satoshi Nozawa et al. (2005). "Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells".PMID 15919668
  74. Yan Ling et al. (2005). "Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells".PMID 15888547
  75. Lucia Gargiulo et al. (2005). "Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide".PMID 15866865
  76. Alexandra Mazharian et al. (2005). "Differential Involvement of ERK2 and p38 in platelet adhesion to collagen".PMID 15851480
  77. Algirdas Ziogas et al. (2005). "CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation".PMID 15845549
  78. Xiaoping Chen et al. (2005). "Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro".PMID 15843428
  79. Nichole Boyer Arnold et al. (2005). "Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein".PMID 15811853
  80. Shougang Zhuang et al. (2005). "p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury".PMID 15797859
  81. Meghan E McMullen et al. (2005). "Activation of p38 has opposing effects on the proliferation and migration of endothelial cells".PMID 15790570
  82. Jong Wook Hong et al. (2005). "Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death".PMID 15788397
  83. Ho Kim et al. (2005). "Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK".PMID 15767259
  84. Bradley S Henson et al. (2005). "Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma".PMID 15767248
  85. Scott K Kuwada et al. (2005). "Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells".PMID 15757908
  86. Jean S Campbell et al. (2005). "Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma".PMID 15728360
  87. Christophe F Deroanne et al. (2005). "Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway".PMID 15728253
  88. Hubert Robitaille et al. (2005). "The mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) acts as a key regulator of keratinocyte terminal differentiation".PMID 15695824
  89. Sang Gu Hwang et al. (2005). "Regulation of beta-catenin signaling and maintenance of chondrocyte differentiation by ubiquitin-independent proteasomal degradation of alpha-catenin".PMID 15695815
  90. Akihiko Numata et al. (2005). "Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway".PMID 15664994
  91. Tie Li et al. (2005). "Epidermal growth factor-induced proliferation requires down-regulation of Pax6 in corneal epithelial cells".PMID 15659382
  92. Dominic De Nardo et al. (2005). "A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors".PMID 15647277
  93. Guru Dutt Sharma et al. (2005). "Epidermal and hepatocyte growth factors, but not keratinocyte growth factor, modulate protein kinase Calpha translocation to the plasma membrane through 15(S)-hydroxyeicosatetraenoic acid synthesis".PMID 15613483
  94. Nicholas E Vlahakis et al. (2005). "The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1".PMID 15590642
  95. Shujuan Chen et al. (2005). "ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation".PMID 15572374
  96. Fang Yan et al. (2004). "Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation".PMID 15520859
  97. William Reiley et al. (2004). "Negative regulation of JNK signaling by the tumor suppressor CYLD".PMID 15496400
  98. Ho Young Lee et al. (2004). "Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells".PMID 15494604
  99. Panos G Ziros et al. (2004). "Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta".PMID 15476590
  100. Lijun Xu et al. (2004). "Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion".PMID 15471877
  101. Makoto Hiromura et al. (2004). "Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1".PMID 15459205
  102. Anna Brancaccio et al. (2004). "Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis".PMID 15367491
  103. Monika Mikolajczyk et al. (2004). "Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90".PMID 15344906
  104. Shr Jeng Leu et al. (2004). "Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions".PMID 15322081
  105. Melanie Keiper et al. (2004). "Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors".PMID 15319437
  106. Md Ruhul Abid et al. (2004). "Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB".PMID 15308628
  107. Purva Bali et al. (2004). "Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3".PMID 15297399
  108. Vidya Mamidipudi et al. (2004). "RACK1 regulates G1/S progression by suppressing Src kinase activity".PMID 15254245
  109. Matthew Wherlock et al. (2004). "Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase".PMID 15226397
  110. Zhibo Yang et al. (2004). "Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells".PMID 15173068
  111. Mizuo Mifune et al. (2004). "Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells".PMID 15163624
  112. Julien Mazieres et al. (2004). "Loss of RhoB expression in human lung cancer progression".PMID 15102679
  113. Lubna Al-Khalili et al. (2004). "ERK1/2 mediates insulin stimulation of Na(+),K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells".PMID 15069082
  114. Xu Shi-Wen et al. (2004). "Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts".PMID 15047866
  115. Kristina Holmqvist et al. (2004). "The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration".PMID 15026417
  116. Saveria Aquila et al. (2004). "Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway".PMID 15001646
  117. Susana Castro-Obregon et al. (2004). "Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77".PMID 14769794
  118. Akihiro Iwabu et al. (2004). "Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway".PMID 14747473
  119. Timothy J King et al. (2004). "Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation".PMID 14742325
  120. Lenin Mahimainathan et al. (2004). "Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase".PMID 14718524
  121. Yingzi Yue et al. (2004). "Ras GTPase-activating protein binds to Akt and is required for its activation".PMID 14707121
  122. Sarah E Ross et al. (2004). "Phosphorylation of C/EBPalpha inhibits granulopoiesis".PMID 14701740
  123. Mireille Toy-Miou-Leong et al. (2004). "Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation".PMID 14699144
  124. Weicheng Liu et al. (2004). "Trihydrophobin 1 is a new negative regulator of A-Raf kinase".PMID 14684750
  125. Astrid A Ruefli-Brasse et al. (2004). "Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation".PMID 14638696
  126. Jeroen P Roose et al. (2003). "T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression".PMID 14624253
  127. Veronique Neaud et al. (2004). "Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism".PMID 14623891
  128. Debora Angeloni et al. (2004). "The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation".PMID 14597639
  129. Brigitte Kasper et al. (2004). "Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase".PMID 14592823
  130. Michael Coon et al. (2003). "Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells".PMID 14578472
  131. Jianghong Li et al. (2003). "Janus kinase 2 and calcium are required for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells".PMID 14565954
  132. Bryan A Ballif et al. (2003). "Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases".PMID 14559149
  133. Yu wen Zhang et al. (2003). "Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation".PMID 14555767
  134. Pilar Munoz et al. (2003). "CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor".PMID 14523017
  135. Fan Li Chou et al. (2003). "PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation".PMID 14506247
  136. Gary S Goldberg et al. (2003). "Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells".PMID 12972425
  137. Min Zhou et al. (2003). "Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8".PMID 12960156
  138. Maddalena Illario et al. (2003). "Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation".PMID 12954639
  139. Yu Li et al. (2003). "Morphine induces desensitization of insulin receptor signaling".PMID 12917346
  140. Rodolphe G Lopez et al. (2003). "v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6)".PMID 12893822
  141. Heather M Wilcox et al. (2003). "Itk phosphorylation sites are required for functional activity in primary T cells".PMID 12842872
  142. Sean R Conner et al. (2003). "Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cells".PMID 12821662
  143. Nathalie Auge et al. (2003). "Pancreatic bile salt-dependent lipase induces smooth muscle cells proliferation".PMID 12821548
  144. Audrey Robinson-White et al. (2003). "Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2".PMID 12812976
  145. G Radziwill et al. (2003). "The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain".PMID 12808105
  146. Hema Vaidyanathan et al. (2003). "RSK2 activity is regulated by its interaction with PEA-15".PMID 12796492
  147. Tara C Polek et al. (2003). "TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor".PMID 12794080
  148. Jaap D van Buul et al. (2003). "Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4".PMID 12766157
  149. Toru Furukawa et al. (2003). "Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer".PMID 12759238
  150. Stephanie J Moeller et al. (2003). "p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation".PMID 12748278
  151. Dongsheng Cai et al. (2003). "Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5".PMID 12730241
  152. Liaoyuan A Hu et al. (2003). "GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation".PMID 12724327
  153. DiAnna L Hynds et al. (2003). "Rit promotes MEK-independent neurite branching in human neuroblastoma cells".PMID 12668729
  154. Mandi M Murph et al. (2003). "Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway".PMID 12668728
  155. Ursula G B Haider et al. (2003). "Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells".PMID 12644594
  156. Julianne M Davis et al. (2003). "Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance".PMID 12631622
  157. Yong Zhu et al. (2003). "Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes".PMID 12574519
  158. Pramod P Naranatt et al. (2003). "Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity".PMID 12502866
  159. Gregory I Liou et al. (2002). "MAP kinase and beta-catenin signaling in HGF induced RPE migration".PMID 12500177
  160. Jian Zhou et al. (2003). "Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer".PMID 12473651
  161. Sanjin Zvonic et al. (2003). "The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes".PMID 12424252
  162. Mitchell Koolpe et al. (2002). "An ephrin mimetic peptide that selectively targets the EphA2 receptor".PMID 12351647
  163. Duncan Howie et al. (2002). "The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production".PMID 12351401
  164. Jena J Steinle et al. (2002). "Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway".PMID 12235151
  165. Evelina Grantcharova et al. (2002). "The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process".PMID 12226103
  166. John K G Crean et al. (2002). "The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells".PMID 12218048
  167. Johan Duchene et al. (2002). "A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation".PMID 12177051
  168. Laurie M Zipper et al. (2002). "The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm".PMID 12145307
  169. Catherine Lavoie et al. (2002). "Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy".PMID 12140284
  170. Giuseppe Pandini et al. (2002). "Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved".PMID 12138094
  171. Young Jun Kim et al. (2002). "Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2".PMID 12124392
  172. Zhong Zong Pan et al. (2002). "Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways".PMID 12121974
  173. Mihail S Iordanov et al. (2002). "The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor".PMID 12101233
  174. Dong Xiao et al. (2002). "Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases".PMID 12097262
  175. Diane Lejeune et al. (2002). "Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10".PMID 12087100
  176. Hideki Murakami et al. (2002). "Role of Dok1 in cell signaling mediated by RET tyrosine kinase".PMID 12087092
  177. Emanuela Lacana et al. (2002). "Cloning and characterization of a protein kinase A anchoring protein (AKAP)-related protein that interacts with and regulates sphingosine kinase 1 activity".PMID 12080051
  178. Rebecca Ruiz-Velasco et al. (2002). "The activation of Rac1 by M3 muscarinic acetylcholine receptors involves the translocation of Rac1 and IQGAP1 to cell junctions and changes in the composition of protein complexes containing Rac1, IQGAP1, and actin".PMID 12070151
  179. Maryse Delehedde et al. (2002). "Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts".PMID 12000311
  180. Takechiyo Yamada et al. (2002). "CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase".PMID 11994288
  181. Shazli N Malik et al. (2002). "Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer".PMID 11948129
  182. Vyacheslav Yurchenko et al. (2002). "Active site residues of cyclophilin A are crucial for its signaling activity via CD147".PMID 11943775
  183. Dayanand D Deo et al. (2002). "Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism".PMID 11940567
  184. Hiroyuki Sano et al. (2002). "Insulin receptor substrate 4 associates with the protein IRAS".PMID 11912194
  185. Junfang Wu et al. (2002). "Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse".PMID 11912190
  186. Jianguo Gu et al. (2002). "Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways".PMID 11891225
  187. Toshiro Niki et al. (2002). "Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas".PMID 11891209
  188. Gieri Camenisch et al. (2002). "ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo".PMID 11877390
  189. Hailing Lu et al. (2002). "Inorganic lead activates the mitogen-activated protein kinase kinase-mitogen-activated protein kinase-p90(RSK) signaling pathway in human astrocytoma cells via a protein kinase C-dependent mechanism".PMID 11861786
  190. Chiara Fiorentini et al. (2002). "Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB".PMID 11818506
  191. Chunrong Yu et al. (2002). "Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells".PMID 11782377
  192. Keyvan Mahboubi et al. (2002). "Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M".PMID 11777927
  193. Veronique Bereziat et al. (2002). "Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14".PMID 11726652
  194. F Blanchard et al. (2001). "Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms".PMID 11602599
  195. S Elowe et al. (2001). "Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction".PMID 11585923
  196. L You et al. (2001). "Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells".PMID 11581189
  197. J Albanell et al. (2001). "Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments".PMID 11522647
  198. Y Dai et al. (2001). "Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells".PMID 11431348
  199. I Fleming et al. (2001). "Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity".PMID 11397791
  200. D Yablonski et al. (2001). "Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT".PMID 11390650
  201. G Hjälm et al. (2001). "Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase".PMID 11390380
  202. J Zhou et al. (2001). "The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2".PMID 11371563
  203. A Schulze et al. (2001). "Analysis of the transcriptional program induced by Raf in epithelial cells".PMID 11316792
  204. C Sweeney et al. (2001). "Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors".PMID 11297548
  205. A Shukla et al. (2001). "Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, fra-1, and S-phase alterations are mediated via oxidative stress".PMID 11280724
  206. A L Siren et al. (2001). "Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress".PMID 11259643
  207. F Chen et al. (2001). "Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite".PMID 11150309
  208. M Aoki et al. (2001). "A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt".PMID 11134523
  209. C C Chen et al. (2001). "The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts".PMID 11120741
  210. A Hans et al. (2001). "Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells".PMID 11073944
  211. D L Persons et al. (2000). "Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin".PMID 10958792